RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma

R Yu, W Wang, T Li, J Li, K Zhao, W Wang… - Future …, 2021 - Taylor & Francis
Definitive chemoradiotherapy is the standard of care for inoperable locoregionally advanced
esophageal squamous cell carcinoma (ESCC). Immune checkpoint inhibitors such as anti …

[HTML][HTML] Application of machine learning approaches to predict the 5-year survival status of patients with esophageal cancer

X Gong, B Zheng, G Xu, H Chen… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Background Accurate prognostic estimation for esophageal cancer (EC) patients plays an
important role in the process of clinical decision-making. The objective of this study was to …

[Retracted] LncRNA OIP5‐AS1 Knockdown Facilitated the Ferroptosis and Immune Evasion by Modulating the GPX4 in Oesophageal Carcinoma

J Hou, Q Huang, Z Fan, H Sang, S Wu… - … Methods in Medicine, 2022 - Wiley Online Library
Objective. Oesophageal cancer (EC) is an extremely invasive malignancy, which has bad
prognosis that requires safe and effective treatment modalities. Immunotherapy has …

Nomograms for predicting survival in early-onset esophageal cancer

M Shi, JW Tang, ZR Cao - Expert Review of Gastroenterology & …, 2021 - Taylor & Francis
Background: This study aimed to develop nomograms predicting the overall survival (OS) of
patients younger than 50 years old with esophageal cancer. Methods: We selected patients …

[HTML][HTML] A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures

J Guo, C Tong, J Shi, X Li, X Chen - Oncology Research, 2024 - ncbi.nlm.nih.gov
Oxidative stress (OS) is intimately associated with tumorigenesis and has been considered a
potential therapeutic strategy. However, the OS-associated therapeutic target for …

[PDF][PDF] Effects of radiotherapy on survival of esophageal cancer patients receiving immunotherapy: Propensity score analysis and nomogram construction

Y Nie, G Yao, L Li, A Feng, W Zhang, X Xu… - Cancer Management …, 2023 - Taylor & Francis
Purpose The present study assessed the effects of radiotherapy on overall survival (OS) and
progression-free survival time (PFS) in patients with stage II or higher esophageal cancer …

Construction of long non-coding RNA-and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer

Q Du, RD Xiao, RG Luo, JB Xie, ZD Su, Y Wang - Plos one, 2022 - journals.plos.org
The current study aimed to explore the lncRNA–miRNA–mRNA networks associated with
alcohol-related esophageal cancer (EC). RNA-sequencing and clinical data were …

Predictive Model for Overall Survival and Cancer‐Specific Survival in Patients with Esophageal Adenocarcinoma

H Huang, W Fang, Y Lin, Z Zheng, Z Wang… - Journal of …, 2021 - Wiley Online Library
Objective. Recent years, there has been a rapid increase in the incidence of esophageal
adenocarcinoma (EAC), while the prognosis for patients diagnosed remains poor and has …

[HTML][HTML] A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy

Y Yu, W Wang, Z Qin, H Li, Q Liu, H Ma… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background There are various treatment options for esophageal squamous cell cancer.
including surgery, peri-operative chemotherapy, and radiation. More recently, neoadjuvant …

Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database

L Xie, Z Zhang - Frontiers in Immunology, 2024 - frontiersin.org
Background While simultaneous chemoradiotherapy remains the established therapeutic
modality for patients afflicted with locally advanced esophageal cancer, the effectiveness of …